8.04
전일 마감가:
$8.08
열려 있는:
$8.12
하루 거래량:
27,972
Relative Volume:
0.18
시가총액:
$303.70M
수익:
-
순이익/손실:
$-27.66M
주가수익비율:
-8.4632
EPS:
-0.95
순현금흐름:
$-24.36M
1주 성능:
+10.14%
1개월 성능:
+80.67%
6개월 성능:
+205.70%
1년 성능:
+150.47%
Genelux Corp Stock (GNLX) Company Profile
명칭
Genelux Corp
전화
805-267-9889
주소
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE
GNLX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
GNLX
Genelux Corp
|
8.04 | 305.21M | 0 | -27.66M | -24.36M | -0.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.18 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
635.96 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.74 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
830.26 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.24 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Genelux Corp Stock (GNLX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-21 | 개시 | Lake Street | Buy |
| 2024-10-29 | 개시 | Guggenheim | Buy |
| 2024-08-28 | 개시 | ROTH MKM | Buy |
| 2023-11-27 | 개시 | H.C. Wainwright | Buy |
| 2023-09-12 | 개시 | Maxim Group | Buy |
| 2023-02-15 | 개시 | The Benchmark Company | Speculative Buy |
모두보기
Genelux Corp 주식(GNLX)의 최신 뉴스
Volume spikes in Genelux Corporation stock – what they meanBond Market & Weekly High Potential Stock Alerts - newser.com
What MACD and RSI say about Genelux Corporation2025 Geopolitical Influence & AI Driven Price Predictions - newser.com
Combining machine learning predictions for Genelux CorporationInflation Watch & Smart Money Movement Alerts - newser.com
Genelux (NASDAQ:GNLX) Trading Up 3.4%Still a Buy? - MarketBeat
Is Genelux Corporation stock trading near support levelsJuly 2025 Selloffs & Real-Time Volume Analysis - newser.com
Genelux initiated with a Buy at Titan Partners - TipRanks
Will earnings trigger a reversal in Genelux CorporationSwing Trade & Reliable Volume Spike Alerts - newser.com
Will Genelux Corporation stock keep outperforming rivalsTrend Reversal & Free Reliable Trade Execution Plans - newser.com
How buybacks impact Genelux Corporation stock value2025 Risk Factors & Weekly Setup with ROI Potential - newser.com
What MACD signals say about Genelux CorporationJuly 2025 Weekly Recap & High Accuracy Investment Signals - newser.com
Visual trend scoring systems applied to Genelux Corporation2025 Geopolitical Influence & AI Driven Price Predictions - newser.com
Statistical indicators supporting Genelux Corporation’s strengthPortfolio Value Summary & Risk Managed Investment Signals - newser.com
Intraday pattern recognizer results for Genelux Corporation2025 Volatility Report & Fast Exit and Entry Trade Guides - newser.com
Will Genelux Corporation see short term momentum2025 Historical Comparison & Stepwise Swing Trade Plans - newser.com
Genelux Corp. Advances Phase 2 Study in NSCLC with Promising New Treatment - TipRanks
Genelux Corp.’s OnPrime Study: A Potential Game-Changer in Ovarian Cancer Treatment - TipRanks
Multi factor analysis applied to Genelux CorporationTrade Analysis Summary & Free Technical Pattern Based Buy Signals - newser.com
Genelux Corporation stock volume spike explainedPortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - newser.com
Genelux (NASDAQ:GNLX) Earns Sell (E+) Rating from Weiss Ratings - MarketBeat
Analysts Set Genelux Corporation (NASDAQ:GNLX) Price Target at $19.25 - Defense World
Genelux Corporation stock retracement – recovery analysis2025 Major Catalysts & High Accuracy Trade Alerts - newser.com
Genelux Corp: Strong Buy Rating Backed by Promising Olvi-Vec Developments and Sector Momentum - TipRanks
GNLX: Lake Street Initiates Coverage with 'Buy' Rating and $16 P - GuruFocus
Lake Street Capital Markets initiates Genelux stock with Buy rating By Investing.com - Investing.com Philippines
Lake Street Capital Markets initiates Genelux stock with Buy rating - Investing.com India
Genelux initiated with a Buy at Lake Street - TipRanks
Genelux Corp (GNLX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):